Impact of GAD65 and IA2 autoantibodies on islet allograft survival is a research paper published in Frontiers in Clinical Diabetes and Healthcare (2023). On theSindex it has a DataRank of 0. It has been cited 3 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCATS NIH HHS
Grant: UL1 TR000460
NIDDK NIH HHS
Grant: R01 DK056953
NIDDK NIH HHS
Grant: U01 DK070460
NCRR NIH HHS
Grant: U42 RR016603
NCRR NIH HHS
Grant: M01 RR016587
NIDDK NIH HHS
Grant: R01 DK025802
NIDDK NIH HHS
Grant: R01 DK055347
National Institutes of Health
Grant: 5M01RR016587-03
CBMS in Advanced Prostate Cancer (Pilot Study)
National Institutes of Health
Grant: 3U42RR016603-05S1
ISLET CELL RESOURCE FOR DIABETES RESEARCH AND TREATMENT
National Institutes of Health
Grant: 3U01DK070460-06S1
Strategies to Improve Long Term Islet Graft Survival
National Institutes of Health
Grant: 5R01DK056953-05
PATHWAYS TO TOLERANCE IN HUMAN ISLET TRANSPLANTATION
National Institutes of Health
Grant: 1UL1TR000460-01A1
Miami Clinical and Translational Science Institute
National Institutes of Health
Grant: 5R01DK025802-10
PANCREATIC TRANSPLANTATION AND DIABETES MELLITUS
National Institutes of Health
Grant: 5R01DK055347-02
IMMUNOMODULATION FOR ISLET TRANSPLANTATION IN DIABETES
FWCI
0.76
Citation Percentile
0.7%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals